The role of CHI3L1 as an oncogenic driver in malignant brain tumors extends beyond gliomas, indicating its importance in tumor aggressiveness, including growth dynamics, migratory tendencies, treatment resistance, and patient survival rates. Here, CHI3L1 is linked to central nervous system cancer.